SignatureFD’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8K Sell
68
-28
-29% -$3.91K ﹤0.01% 2604
2025
Q4
$15.7K Buy
96
+53
+123% +$8.3K ﹤0.01% 2226
2025
Q3
$5.75K Sell
43
-107
-71% -$13K ﹤0.01% 2620
2025
Q2
$18.7K Sell
150
-174
-54% -$22.1K ﹤0.01% 2084
2025
Q1
$41.2K Buy
324
+128
+65% +$19.7K ﹤0.01% 1691
2024
Q4
$28.2K Buy
196
+124
+172% +$17.8K ﹤0.01% 1885
2024
Q3
$10.7K Sell
72
-120
-63% -$17.2K ﹤0.01% 2309
2024
Q2
$24.2K Sell
192
-288
-60% -$45.1K ﹤0.01% 1867
2024
Q1
$88.3K Buy
480
+63
+15% +$12K ﹤0.01% 1257
2023
Q4
$75K Buy
417
+136
+48% +$21.2K ﹤0.01% 1264
2023
Q3
$44.7K Buy
281
+86
+44% +$14.1K ﹤0.01% 1448
2023
Q2
$27.6K Sell
195
-222
-53% -$35.6K ﹤0.01% 1729
2023
Q1
$70.2K Sell
417
-52
-11% -$9.28K ﹤0.01% 1216
2022
Q4
$79.4K Hold
469
﹤0.01% 1123
2022
Q3
$88K Buy
469
+57
+14% +$12K ﹤0.01% 1023
2022
Q2
$67K Buy
412
+10
+2% +$1.58K ﹤0.01% 1158
2022
Q1
$76K Buy
402
+110
+38% +$20.9K ﹤0.01% 1172
2021
Q4
$77K Buy
292
+77
+36% +$20.7K ﹤0.01% 1142
2021
Q3
$62K Buy
215
+40
+23% +$10.3K ﹤0.01% 1198
2021
Q2
$35K Sell
175
-31
-15% -$6.01K ﹤0.01% 1447
2021
Q1
$40K Buy
206
+83
+67% +$17K ﹤0.01% 1276
2020
Q4
$24K Sell
123
-8
-6% -$1.46K ﹤0.01% 1379
2020
Q3
$19K Buy
131
+7
+6% +$1K ﹤0.01% 1407
2020
Q2
$15K Buy
124
+20
+19% +$2.35K ﹤0.01% 1432
2020
Q1
$10K Buy
104
+29
+39% +$2.8K ﹤0.01% 1483
2019
Q4
$7K Hold
75
﹤0.01% 1568
2019
Q3
$6K Hold
75
﹤0.01% 1576
2019
Q2
$6K Hold
75
﹤0.01% 1541
2019
Q1
$4K Buy
+75
New +$4.31K ﹤0.01% 1638

Other funds holding RGEN

SignatureFD's RGEN Position: Q1 2026 in Review

SignatureFD reduced its Repligen (RGEN) stake by 29% in Q1 2026, selling an estimated $3.91K and leaving 68 shares worth $8K. The position accounts for ﹤0.01% of the portfolio, ranked #2604.

SignatureFD first reported a position in RGEN in Q1 2019 and has held it in 29 quarters since. The position peaked at $88.3K in Q1 2024. 441 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.

  • SignatureFD held 68 shares of Repligen worth $8K as of Q1 2026.
  • SignatureFD sold 28 Repligen shares in Q1 2026, an estimated $3.91K.
  • Repligen made up ﹤0.01% of SignatureFD's portfolio in Q1 2026, its #2604 holding.
  • SignatureFD first reported a position in Repligen in Q1 2019 and has held it in 29 quarters since.
  • SignatureFD's Repligen position peaked at $88.3K in Q1 2024.
  • 441 funds tracked by Wall St. Rank held Repligen as of Q1 2026.

Based on SignatureFD's 13F filing for Q1 2026, filed 7 Apr 2026.